Use of gaseous nitric oxide as an anti-cancer agent

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11704791

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a method for treating, controlling, or preventing cancerous cell phenotypes and growths in an animal involving the administration of gaseous nitric oxide to one or administration sites in a body. The invention generally is capable of treating cancers found in or on the adrenal gland, bladder, bones, brain, breast, cervix, colon, colorectum, esophagus, gastrointestinal tract, heart, kidney, liver, large intestine, lungs, mouth, ovaries, pancreas, parathyroid, pituitary gland, prostate, salivary gland, skin, small intestine, spleen, stomach, thymus, thyroid, testicles, urinary tract, uterus, vagina, and so forth.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PULMONOX TECHNOLOGIES CORPORATION#107 10835 - 120 STREET EDMONTON ALBERTA T5H 3P3

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Miller, Christopher C North Vancouver, CA 138 24364

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation